|

KC1036 Clinical Trials

6 actively recruiting trials

Pipeline

Phase 1: 1Phase 2: 3Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Beijing Konruns Pharmaceutical Co., Ltd.6

Indications

  • Cancer6
  • Digestive System Tumors1
  • Esophageal Squamous Cell Carcinoma1
  • Thymic Tumors1
  • Ewing Sarcoma1

Other6 trials

A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
Phase 3
A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma
Phase 2
A Study of KC1036 in Patients with Advanced Solid Tumors
Phase 1
A Study of KC1036 in Patients with Advanced Thymic Tumors
Phase 2
KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer
Phase 2
To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.